Heat shock factor 2-binding protein promotes tumor progression via activation of MAPK signaling pathway in lung adenocarcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. [ published Online First: 2021/02/05].
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–1640. [ published Online First: 2019/08/06].
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer,version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(4):504–535. [ published Online First: 2017/04/14].
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. [ published Online First: 2018/01/25].
   PubMed Web of Science ®Google Scholar
• Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377(9):849–861. [ published Online First: 2017/08/31].
   PubMed Web of Science ®Google Scholar
• Wang J, Shi W, Miao Y, et al. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Bioengineered. 2021;12(1):6286–6304. [ published Online First: 2021/09/09].
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang W, Yang Y, et al. Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma. Bioengineered. 2021;12(1):4747–4756. [ published Online First: 2021/08/03].
   PubMed Web of Science ®Google Scholar
• Pearlman R, Frankel WL, Swanson B, et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3(4):464–471. [ published Online First: 2016/12/16].
   PubMed Web of Science ®Google Scholar
• Wang HL, Liu PF, Yue J, et al. Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel. Cancer Lett. 2020;470:181–190. [ published Online First: 2019/11/26].
   PubMed Web of Science ®Google Scholar
• Hoppe MM, Sundar R, Tan DSP, et al. Biomarkers for homologous recombination deficiency in cancer. J Natl Cancer Inst. 2018;110(7):704–713. [ published Online First: 2018/05/23].
   PubMedGoogle Scholar
• Nguyen L, J WMM, Van Hoeck A, et al. Pan-cancer landscape of homologous recombination deficiency. Nat Commun. 2020;11(1):5584. [ published Online First: 2020/11/06].
   PubMed Web of Science ®Google Scholar
• Yoshima T, Yura T, Yanagi H. Novel testis-specific protein that interacts with heat shock factor 2. Gene. 1998;214(1–2):139–146. [ published Online First: 1998/07/04].
   PubMed Web of Science ®Google Scholar
• Wu Y, Liao S, Wang X, et al. HSF2BP represses BNC1 transcriptional activity by sequestering BNC1 to the cytoplasm. FEBS Lett. 2013;587(14):2099–2104. [ published Online First: 2013/05/28].
   PubMed Web of Science ®Google Scholar
• Brandsma I, Sato K, van Rossum-fikkert SE, et al. HSF2BP interacts with a conserved domain of BRCA2 and is required for mouse spermatogenesis. Cell Rep. 2019;27(13):3790–98 e7. [ published Online First: 2019/06/27].
   PubMed Web of Science ®Google Scholar
• Zhang J, Fujiwara Y, Yamamoto S, et al. A meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination. Nat Commun. 2019;10(1):722. [ published Online First: 2019/02/15].
   PubMedGoogle Scholar
• Felipe-Medina N, Caburet S, Sanchez-Saez F, et al. A missense in HSF2BP causing primary ovarian insufficiency affects meiotic recombination by its novel interactor C19ORF57/BRME1. Elife. 2020;9. [ published Online First: 2020/08/28]. DOI:10.7554/eLife.56996.
   PubMed Web of Science ®Google Scholar
• Sato K, Brandsma I, van Rossum-fikkert SE, et al. HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair. Nucleic Acids Res. 2020;48(5):2442–2456. [ published Online First: 2020/01/22].
   PubMed Web of Science ®Google Scholar
• Tajan M, Paccoud R, Branka S, et al. The RASopathy family: consequences of germline activation of the RAS/MAPK pathway. Endocr Rev. 2018;39(5):676–700. [ published Online First: 2018/06/21].
   PubMed Web of Science ®Google Scholar
• Zou X, Blank M. Targeting p38 MAP kinase signaling in cancer through post-translational modifications. Cancer Lett. 2017;384:19–26. [ published Online First: 2016/10/28].
   PubMed Web of Science ®Google Scholar
• Drosten M, Barbacid M. Targeting the MAPK pathway in KRAS-Driven tumors. Cancer Cell. 2020;37(4):543–550. [ published Online First: 2020/04/15].
   PubMed Web of Science ®Google Scholar
• Manchado E, Weissmueller S, Morris J, et al. A combinatorial strategy for treating KRAS-mutant lung cancer. Nature. 2016;534(7609):647–651. [ published Online First: 2016/06/25].
   PubMed Web of Science ®Google Scholar
• Sato H, Schoenfeld AJ, Siau E, et al. MAPK pathway alterations correlate with poor survival and drive resistance to therapy in patients with lung cancers driven by ROS1 fusions. Clin Cancer Res off J Am Assoc Cancer Res. 2020;26(12):2932–2945. [ published Online First: 2020/03/04].
   PubMed Web of Science ®Google Scholar
• Stutvoet TS, Kol A, de Vries EG, et al. MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells. J Pathol. 2019;249(1):52–64. [ published Online First: 2019/04/12].
   PubMed Web of Science ®Google Scholar